Search hospitals > New York > Albany
New York Oncology Hematology, PC
Claim this profileAlbany, New York 12206
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
185 reported clinical trials
5 medical researchers
Summary
New York Oncology Hematology, PC is a medical facility located in Albany, New York. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. New York Oncology Hematology, PC is involved with conducting 185 clinical trials across 151 conditions. There are 5 research doctors associated with this hospital, such as Karen Tedesco, Rahul Ravilla, MD, Mihir Raval, MD, and Lawrence E. Garbo, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
HER2 positive
Stage IV
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Karen TedescoUSO - New York Oncology Hematology7 years of reported clinical research
Studies Breast Cancer
6 reported clinical trials
14 drugs studied
Rahul Ravilla, MDNew York Oncology Hematology, P.C.3 years of reported clinical research
Studies Cancer
Studies Prostate Cancer
4 reported clinical trials
9 drugs studied
Mihir Raval, MDNew York Oncology Hematology, P.C.5 years of reported clinical research
Studies Lymphoma
Studies Plasma Cell Neoplasms
4 reported clinical trials
12 drugs studied
Lawrence E. Garbo, MDNew York Oncology Hematology, P.C.1 year of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Gallbladder Cancer
2 reported clinical trials
4 drugs studied
Clinical Trials running at New York Oncology Hematology, PC
Colorectal Cancer
Follicular Lymphoma
Multiple Myeloma
Ovarian Cancer
Breast Cancer
Gallbladder Cancer
Biliary Tract Cancer
Melanoma
Tumors
Bile Duct Cancer
RO7198457
for Colorectal Cancer
This is a multi-site, open-label, Phase II, randomized, trial to compare the efficacy of RO7198457 versus watchful waiting in patients with circulating tumor DNA (ctDNA) positive, surgically resected Stage II/III rectal cancer, or Stage II (high risk)/Stage III colon cancer.
Recruiting1 award Phase 29 criteria
Combo Therapy
for Colorectal Cancer
This is a Phase 1b/2 study to investigate the efficacy and safety of LBL-007 plus Tislelizumab when administered in combination with bevacizumab plus fluoropyrimidine to participants with colorectal cancer.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at New York Oncology Hematology, PC?
New York Oncology Hematology, PC is a medical facility located in Albany, New York. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. New York Oncology Hematology, PC is involved with conducting 185 clinical trials across 151 conditions. There are 5 research doctors associated with this hospital, such as Karen Tedesco, Rahul Ravilla, MD, Mihir Raval, MD, and Lawrence E. Garbo, MD.